Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

86.77 +1.44 (+1.69%)
Official Closing Price Updated: 7:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardinal Health

< Previous 1 2 3 4 5 6 7 Next >
Cardinal Health Post Mixed Q1 Earnings; Reaffirms FY22 Adjusted EPS Outlook
Cardinal Health (NYSE: CAH) reported Q1 FY22 adjusted EPS of $1.29, down from $1.51 a year ago, missing the Street estimate of $1.33. Q1 sales increased 13% Y/Y to $44... 
Via Benzinga
5 Stocks Getting Crushed - Are They Buying Opportunities?
Five dividend growth stocks that are down at least 20% from highs. 
Via Talk Markets
Got $10,000? These 3 Dividend Stocks Are on Sale
Make the most of your money with these income-producing investments. 
Via The Motley Fool
Industry Leaders Chart Future of Supply Chain Visibility
Shopping has never been easier for the consumer. They can have products delivered within a few hours, the same day, the next day, or in two days. They can shop in person, online,... 
Via Benzinga
Drug Distributors Ink First Opioid Settlement With Cherokee Nation
Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have... 
Via Benzinga
Analyzing Cardinal Health's Unusual Options Activity
On Tuesday, shares of Cardinal Health (NYSE:CAH) saw unusual... 
Via Benzinga
The Next Major Cardinal Health (CAH) Trade Level
The next major support level for Cardinal Health Inc stock will be around the $46.00 level. This key support area is where the stock broke out to the upside in early November 2020. 
Via Talk Markets
Unusual Options Activity Insight: Cardinal Health
On Friday, shares of Cardinal Health (NYSE:CAH) saw unusual ... 
Via Benzinga
89 Firms going Ex-Dividend next week, including Philip Morris, Cardinal Health and Nutrien
Several well-known large-cap stocks going ex-dividend next week 
Via Talk Markets
25 Best & 10 Cheapest Dividend Aristocrats
These are blue-chip dividend-paying stocks that have increased their dividend for at least 25 consecutive years or longer. 
Via Talk Markets
Endo Shares Move Higher On Settlement Of New York State Opioid Cases
Endo International plc (NASDAQ: ENDP) has agreed to pay $50 million to resolve lawsuits by New York state and two of its largest counties related to the sale and... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
3 Model Dividend Growth Portfolios for 3 Different Objectives
A look at three dividend growth portfolios that can be built in today’s generally overvalued market. 
Via Talk Markets
NRx Pharma, Cardinal Health Ink Zyesami Distribution Pact
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has signed an agreement with Cardinal Health Inc (NYSE: CAH) to provide third-party logistics and distribution of Zyesami upon the... 
Via Benzinga
Could These 2 Dividend Aristocrats Break Their Payout-Hiking Streaks Next Year?
Cardinal Health and Clorox have posted some disappointing results lately. 
Via The Motley Fool
Exposures COVID-19
Key Dividend Increases from Last Week Including Simon Property Group And Cardinal Health
Stocks that raised dividends last week. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021
Upgrades According to Wolfe Research, the prior rating for The AES Corp (NYSE: 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
Cardinal Health Stock Loses 14% As Q4 Earnings Disappoint; Expects COVID-19 Tailwinds To Impact FY22
Cardinal Health (NYSE: CAH) reported fourth-quarter adjusted earnings today that were only two-thirds of what The Street expected. The Company posted an adjusted... 
Via Benzinga
Exposures COVID-19
Cardinal Health, inc (CAH) Q4 2021 Earnings Call Transcript
CAH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Cardinal Health Is Down Nearly 13% Today
Investors are reading a lot (perhaps too much) into an accounting decision made in the early days of the COVID-19 pandemic. 
Via The Motley Fool
Exposures COVID-19
A Peek Into The Markets: US Stock Futures Up Ahead Of Jobless Claims Data
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones tumbled more than 300 points in the previous session. Investors are awaiting... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Stocks To Watch For August 5, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Kellogg Company (NYSE: K) to report quarterly earnings at $1.02 per share on revenue of $3.41... 
Via Benzinga
Another Big Earnings Week Ahead
After a monumental week of Big Tech earnings, we're in for more than a quarter of S&P 500 companies' reports, including those from Alibaba (NYSE: BABA), General Motors... 
Via Benzinga
Topics Stocks
Exposures US Equities
Drug Distributors To Pay Up To $1.1B To Settle New York Opioid Claims
McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) have agreed to pay up to $1.179 billion... 
Via Benzinga
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic. 
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal
Opioid Settlement Of $26B Between Drug Companies, States To Potentially Conclude This Week
U.S. states attorneys general are expected to conclude the $26B settlement with three drug distributors and Johnson & Johnson (NYSE: JNJ) this week... 
Via Benzinga
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly... 
Via Benzinga
JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst
Over the weekend, Johnson & Johnson (NYSE:JNJ) reached a ... 
Via Benzinga
Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide
The company has said that it has not marketed opioids in the U.S. since 2015 and discontinued the business in 2020. JNJ did not admit liability in settling with New York State, Nassau, and Suffolk... 
Via Talk Markets
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.